Microbial transglutaminase: A new potential player in celiac disease

被引:35
|
作者
Aaron, Lerner [1 ,2 ]
Torsten, Matthias [2 ]
机构
[1] Technion Israel Inst Technol, B Rappaport Sch Med, Haifa, Israel
[2] AESKU KIPP Inst, Mikroforum Ring 2, D-55234 Wendelsheim, Germany
关键词
Celiac disease; Enzyme; Microbial; Food additive; Gluten; Microbial transglutaminase; ANTIBIOTIC-RESISTANCE GENES; BIOTECHNOLOGICAL APPLICATIONS; TISSUE TRANSGLUTAMINASE; SUBSTRATE-SPECIFICITY; GUT MICROBIOTA; WHEAT-FLOUR; FOOD; GLUTEN; GLIADIN; PROTEIN;
D O I
10.1016/j.clim.2018.12.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microbial transglutaminase is heavily used in the food processing industries to improve food qualities. Being a protein's glue, by cross-linking it creates neoepitope complexes that are immunogenic and potentially pathogenic in celiac disease. Despite low sequence identity, it imitates functionally its family member, the endogenous tissue transglutaminase, which is the autoantigen of celiac disease. The present comprehensive review highlights the enzyme characteristics, endogenous and exogenous intestinal sources, its cross-talks with gluten and gliadin, its immunogenicity and potential pathogenicity and risks for the gluten induced conditions. If substantiated, it might represent a new environmental inducer of celiac disease. The present findings might affect nutritional product labeling, processed food additive policies and consumer health education.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [21] Tissue transglutaminase: Master regulator of celiac disease?
    Mearin, ML
    Koning, F
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2003, 36 (01): : 9 - 11
  • [22] Role of transglutaminase 2 in celiac disease pathogenesis
    Klock, Cornelius
    DiRaimondo, Thomas R.
    Khosla, Chaitan
    SEMINARS IN IMMUNOPATHOLOGY, 2012, 34 (04) : 513 - 522
  • [23] Transglutaminase 2 in celiac disease: Minireview article
    I. Caputo
    A. D’Amato
    R. Troncone
    S. Auricchio
    C. Esposito
    Amino Acids, 2004, 26 : 381 - 386
  • [24] Identification of tissue transglutaminase as the autoantigen of celiac disease
    Dieterich, W
    Ehnis, T
    Bauer, M
    Donner, P
    Volta, U
    Riecken, EO
    Schuppan, D
    NATURE MEDICINE, 1997, 3 (07) : 797 - 801
  • [25] Transglutaminase 2 in celiac disease: Minireview article
    Caputo, I
    D'Amato, A
    Troncone, R
    Auricchio, S
    Esposito, C
    AMINO ACIDS, 2004, 26 (04) : 381 - 386
  • [26] Autoantibodies to tissue transglutaminase as predictors of celiac disease
    Dieterich, W
    Laag, E
    Schöpper, H
    Volta, U
    Ferguson, A
    Gillett, H
    Riecken, EO
    Schuppan, D
    GASTROENTEROLOGY, 1998, 115 (06) : 1317 - 1321
  • [27] Tissue transglutaminase in celiac disease: role of autoantibodies
    Caputo, Ivana
    Barone, Maria Vittoria
    Martucciello, Stefania
    Lepretti, Marilena
    Esposito, Carla
    AMINO ACIDS, 2009, 36 (04) : 693 - 699
  • [28] Transglutaminase 2 inhibitor for treatment of celiac disease
    Dietz, Christopher
    Wedemeyer, Heiner
    Nitschmann, S.
    INTERNIST, 2021, 62 (12): : 1364 - 1366
  • [29] Identification of tissue transglutaminase as the autoantigen of celiac disease
    Walburga Dieterich
    Tobias Ehnis
    Michael Bauer
    Peter Donner
    Umberto Volta
    Ernst Otto Riecken
    Detlef Schuppan
    Nature Medicine, 1997, 3 : 797 - 801
  • [30] Role of transglutaminase 2 in celiac disease pathogenesis
    Cornelius Klöck
    Thomas R. DiRaimondo
    Chaitan Khosla
    Seminars in Immunopathology, 2012, 34 : 513 - 522